Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder
- Conditions
- Bipolar Affective Disorder
- Interventions
- Device: Smartphone APP
- Registration Number
- NCT03275714
- Lead Sponsor
- Medical University of Graz
- Brief Summary
The primary objective of the clinical trial is to evaluate the data of an app for smartphones (BiP-App) with regard to sleep, movement, mood and communication behavior.
The data will be compared between two groups: people with a bipolar affective disorder and individuals without a psychiatric disorder.
Secondary objective of the trial is to investigate if it is possible to detect early warning symptoms of depressive / (hypo) manic episodes via the measured behavior patterns.
Furthermore it will be evaluated whether the BiP-app can find applicability in the examined patient group.
Study design: Clinical evaluation of a medical device without CE mark; Parallel study design
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
- Written consent of the participant after clarification
- Patients with a bipolar affective disorder (group of patients) Or control persons without a mental illness (control group)
- Age between 18 and 70 years
- Knowledge about using a smartphone
- Rejection of participation
- Lack of knowledge about how to deal with a smartphone
- Congenital / early-childhood intelligence reduction
- Moderate / severe dementia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description People With a Bipolar Affective Disorder Smartphone APP - Control subjects without a psychiatric disorder Smartphone APP -
- Primary Outcome Measures
Name Time Method Mood 6 months evaluated by mood surveys
Sleep duration 6 months in minutes
Movement behaviour 6 months evaluated through motion sensors and localization services
Communication behaviour 6 months Frequency of usage of communication services
- Secondary Outcome Measures
Name Time Method Patient acceptance 6 months evaluated by a questionnaire
Trial Locations
- Locations (1)
Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
🇦🇹Graz, Austria